Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-01 20:14:12 - browse：7

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Scientists successfully use ultrasound imaging to map brain activity

hotspot

WSS

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Average age of first period drops to 11.9 years, study shows

What will save rural psychiatry services? Higher Medicaid payments

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

knowledge

Wikipedia

knowledge

Walensky prepares to leave CDC — and Congress — behind

Alabama hospital puts IVF treatments on hold

DIEP, the 'gold standard' of breast reconstruction, is under threat

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medicare inequities exacerbate Puerto Rico’s health disparities

After affirmative action ruling, medical educators look to 'holistic review'

STAT readers on older presidents, polypills, Medicare, and more

How to save PrEP access — and even expand it

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Wikipedia

Lab trade group sues FDA to halt regulation of lab

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Insmed lung disease drug hits target in key Phase 3 trial

He's a Nobel laureate. Critics say he was misleading on Covid

In utero gene editing: an explainer

Biohaven protein

hotspot

Wikipedia

leisure time

hotspot